BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17382917)

  • 21. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
    Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
    Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
    Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
    Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
    Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen activators are involved in the degradation of bone by osteoclasts.
    Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
    Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells.
    Hsu HH; Hu WS; Lin YM; Kuo WW; Chen LM; Chen WK; Hwang JM; Tsai FJ; Liu CJ; Huang CY
    J Biomed Sci; 2011 Aug; 18(1):61. PubMed ID: 21859479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
    Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
    J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
    Kiyan J; Haller H; Dumler I
    Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased bone formation in mice lacking plasminogen activators.
    Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
    J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro.
    Zhao Y; Li JS; Guo MZ; Feng BS; Zhang JP
    Chin J Cancer; 2010 Aug; 29(8):752-60. PubMed ID: 20663323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of fibrinolytic genes and proteins in the development of allograft vascular disease.
    Benza RL; Passineau MJ; Anderson PG; Barchue JP; George JF
    J Heart Lung Transplant; 2011 Aug; 30(8):935-44. PubMed ID: 21652221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
    EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
    Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
    Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AP-1 inhibits expression of MMP-2/9 and its effects on rat smooth muscle cells.
    Zhang HW; Wang X; Zong ZH; Huo X; Zhang Q
    J Surg Res; 2009 Nov; 157(1):e31-7. PubMed ID: 19524937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis.
    Deindl E; Ziegelhöffer T; Kanse SM; Fernandez B; Neubauer E; Carmeliet P; Preissner KT; Schaper W
    FASEB J; 2003 Jun; 17(9):1174-6. PubMed ID: 12692088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.